Form 8-K - Current report:
SEC Accession No. 0001628280-21-003067
Filing Date
2021-02-24
Accepted
2021-02-24 16:14:27
Documents
18
Period of Report
2021-02-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K auph-20210224.htm   iXBRL 8-K 49415
2 EX-99.1 exhibit991_aurinianewsrele.htm EX-99.1 91676
3 EX-99.2 exhibit992_auph-20200331xq.htm EX-99.2 269745
4 EX-99.3 exhibit993_auph-20200630xq.htm EX-99.3 341148
5 EX-99.4 exhibit994_auph-20200930xq.htm EX-99.4 359312
  Complete submission text file 0001628280-21-003067.txt   1351058

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20210224.xsd EX-101.SCH 2451
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20210224_cal.xml EX-101.CAL 732
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20210224_def.xml EX-101.DEF 1669
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20210224_lab.xml EX-101.LAB 23970
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20210224_pre.xml EX-101.PRE 12668
11 EXTRACTED XBRL INSTANCE DOCUMENT auph-20210224_htm.xml XML 11099
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36421 | Film No.: 21673297
SIC: 2834 Pharmaceutical Preparations